Skip to content
10-Q

Quarterly Report

ADC Therapeutics SA ADCT

0001771910-25-000008

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 112.5M sh
Shares Diluted Q2 2025 · Jun 30, 2025 113.74M sh
Shares Diluted Q2 2025 · Jun 30, 2025 110.49M sh
Shares Diluted Q2 2025 · Jun 30, 2024 95.69M sh
Shares Diluted Q2 2025 · Jun 30, 2024 89.12M sh
Capex Q2 2025 · Jun 30, 2025 $264K
Capex Q2 2025 · Jun 30, 2024 $561K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$80.42M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$76.94M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $264.56M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $250.87M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$199.18M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$238.22M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$202.64M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$131.67M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$194.45M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$148.25M
Current Liabilities Q2 2025 · Jun 30, 2025 $64.6M
Current Liabilities Q2 2025 · Dec 31, 2024 $80.47M
Total Liabilities Q2 2025 · Jun 30, 2025 $520.75M
Total Liabilities Q2 2025 · Dec 31, 2024 $524.62M
Current Assets Q2 2025 · Jun 30, 2025 $318.76M
Current Assets Q2 2025 · Dec 31, 2024 $307.39M
Total Assets Q2 2025 · Jun 30, 2025 $321.56M
Total Assets Q2 2025 · Dec 31, 2024 $321.98M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.50
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.86
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.38
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.93
Eps Basic Q2 2025 · Jun 30, 2025 −$0.50
Eps Basic Q2 2025 · Jun 30, 2025 −$0.86
Eps Basic Q2 2025 · Jun 30, 2024 −$0.38
Eps Basic Q2 2025 · Jun 30, 2024 −$0.93
Sga Expense Q2 2025 · Jun 30, 2025 $8.82M
Sga Expense Q2 2025 · Jun 30, 2025 $18.78M
Sga Expense Q2 2025 · Jun 30, 2024 $10.24M
Sga Expense Q2 2025 · Jun 30, 2024 $22.27M
Rd Expense Q2 2025 · Jun 30, 2025 $30.09M
Rd Expense Q2 2025 · Jun 30, 2025 $59.02M
Rd Expense Q2 2025 · Jun 30, 2024 $24.3M
Rd Expense Q2 2025 · Jun 30, 2024 $50.03M
Net Income Q2 2025 · Jun 30, 2025 −$56.65M
Net Income Q2 2025 · Jun 30, 2025 −$95.25M
Net Income Q2 2025 · Jun 30, 2024 −$36.54M
Net Income Q2 2025 · Jun 30, 2024 −$83.15M
Operating Income Q2 2025 · Jun 30, 2025 −$44.15M
Operating Income Q2 2025 · Jun 30, 2025 −$72.61M
Operating Income Q2 2025 · Jun 30, 2024 −$29.04M
Operating Income Q2 2025 · Jun 30, 2024 −$62.65M
Revenue Q2 2025 · Jun 30, 2025 $18.09M
Revenue Q2 2025 · Jun 30, 2025 $35.49M
Revenue Q2 2025 · Jun 30, 2024 $17.03M
Revenue Q2 2025 · Jun 30, 2024 $34.88M